Knowledge, attitude and practice towards COVID-19 vaccination acceptance in West India

Author:

Bhartiya Shibal,Kumar Nishant,Singh Tarundeep,Murugan Sathiabalan,Rajavel Saranya,Wadhwani Meenakshi

Abstract

Background: Coronavirus disease 2019 (COVID-19) pandemic has affected more than 200 countries causing loss of life and livelihood. The accelerated development of the COVID-19 vaccine is a vital development, and early data suggests that it is both, safe and efficacious. However, the acceptance of COVID-19 vaccine depends on various socio-demographic characteristics. The aim of this study was to understand the knowledge and attitude towards COVID-19 vaccine in India.  Methods: This is a cross-sectional study done in an urban slum in Mumbai, India. The main outcome variable was the responses related to COVID-19 vaccine acceptance among the study participants.Results: A total of 1342 participants were included in the study. Almost two thirds (64.5%) of the young adults aged between 18 and 40 years were unaware about the COVID-19 vaccine availability, followed by 56.4% person aged between 40 and 60 years and 46.2% of the persons aged more than 60 years were unaware about the vaccine availability. Among the study participants, nearly 79% were willing to take COVID-19 vaccine when it is available for use and only 2% did not want the vaccination. More than 2/3rd of the people who responded that they are willing to accept the COVID vaccine belong to the no income group.Conclusions: The most important factor for vaccine hesitancy is the occurrence of mild or serious adverse effects following immunization. Vaccine acceptability may be increased once additional information about vaccine safety and efficacy is available in the public domain, preferably from a trusted, centralized source of information.  

Publisher

Medip Academy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3